Intuitive Surgical, US46120E6023

Intuitive Surgical stock gains on Q2 growth and earnings beat

Published on 09/02/2026 at 10:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock is supported by Q2 2026 revenue of USD 2.89 billion and EPS of USD 2.80. Analysts also track a market cap above USD 133 billion and a consensus price target near USD 509.

Schwarz-Weiß-Dokumentarfoto eines Chirurgen in Konzentration an einer Steuerkonsole mit mehreren OP-Monitoren, dramatische Seitenlicht-Schatten, Operationssaal unscharf im Hintergrund
Intuitive Surgical US46120E6023 Schwarz-Weiß-Reportage zeigt Chirurgen an der Steuerkonsole mit operativem Monitor-Array, Illustration mit AI erstellt.

Intuitive Surgical stock (ISIN US46120E6023) is trading around USD 376.86, with a market cap of USD 133.14 billion as of September 1, 2026. The latest quarterly report showed EPS of USD 2.80 and revenue of USD 2.89 billion for Q2 2026, both above analyst expectations.

Q2 figures set the tone

MarketBeat said on September 1, 2026 that Intuitive Surgical recently exceeded quarterly EPS and revenue expectations, with EPS of USD 2.80 versus USD 2.48 expected and revenue of USD 2.89 billion versus USD 2.83 billion expected. That same update put the stock price at USD 376.86, the 12-month range at USD 328.57 to USD 603.88, and the market cap at USD 133.14 billion.

The comparison is clear: revenue rose 18.4 percent year over year, and EPS climbed from USD 1.81 in the same quarter last year to USD 2.80. The company also reported a net margin of 28.45 percent and return on equity of 16.91 percent.

Consensus stays positive

Analysts cited by MarketBeat kept a Moderate Buy view with an average price target of USD 508.68 as of September 1, 2026. Barchart reported a Strong Buy consensus from 31 analysts, with a mean target of USD 483.34, which sits above the latest quoted price.

That leaves the stock between a strong quarterly report and a valuation debate. Yahoo Finance showed a 52-week range of USD 254.85 to USD 496.48, underlining how far the shares have already moved this year.

Go deeper

Da Vinci remains the core driver

The robot-assisted da Vinci system still anchors the business, while procedure growth and installed systems remain the main operating signals.

Da Vinci and Ion scale

The Globe and Mail reported on September 1, 2026 that cardiac procedures accelerated 39 percent in the second quarter, while Ion procedures increased 36 percent to 48,000 and cumulative Ion procedures topped 400,000. MoneyDJ said Q2 2026 revenue grew 19 percent, total procedures rose 16 percent, and the global da Vinci and Ion installed base approached 13,000 systems.

Price below the high

Intuitive Surgical stock finished at USD 376.86 on September 1, 2026, compared with a 12-month high of USD 603.88 and a low of USD 328.57. The same market snapshot showed a 50-day moving average of USD 384.07 and a 200-day moving average of USD 431.50.

Fact box

Intuitive Surgical at a glance

  • Company: Intuitive Surgical, Inc.
  • ISIN: US46120E6023
  • Ticker: ISRG
  • Trading venue: NASDAQ
  • Price (as of September 1, 2026): USD 376.86
  • Market capitalization: USD 133.14 billion (as of September 1, 2026)
  • Sector / Industry: Health Care / Health Care Equipment & Supplies
  • Index membership: S&P 500

Follow the stock

Disclaimer...

en | US46120E6023 | INTUITIVE SURGICAL | boerse | 70041925 | bgmi